Glenmark Pharmaceuticals rises on incorporating wholly-owned subsidiary

15 May 2023 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 613.55, up by 0.85 points or 0.14% from its previous closing of Rs. 612.70 on the BSE.

The scrip opened at Rs. 613.00 and has touched a high and low of Rs. 617.70 and Rs. 608.90 respectively. So far 19882 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 615.80 on 15-May-2023 and a 52 week low of Rs. 348.90 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 617.70 and Rs. 550.50 respectively. The current market cap of the company is Rs. 17281.39 crore.

The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 32.90% and 20.45% respectively.

Glenmark Pharmaceuticals has incorporated wholly-owned subsidiary namely - ‘Glenmark Healthcare’ on May 12, 2023. The company has incorporated wholly-owned subsidiary to carry out manufacturing and trading of Pharmaceutical products.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

802.25 -25.80 (-3.12%)
22-Sep-2023 18:02 View Price Chart
Company Name CMP
Sun Pharma Inds. 1131.60
Dr. Reddys Lab 5516.35
Cipla 1186.60
Zydus Lifesciences 595.60
Lupin 1097.05
View more..